Skip to main content

The outcome of studies using Toujeo (insulin glargine 300 units/mL) in patients with Type 1 and Type 2 Diabetes: expanding the evidence base

Symposium sponsored by Sanofi Presented at the ABCD Autumn Meeting 2018
Chairman introduction, Professor Mike Baxter, Sanofi
BRIGHT study: Results of the first head-to-head randomised clinical trial comparing the efficacy and safety of Toujeo vs insulin degludec in T2 Diabetes. Prof Vinod Patel Nuneaton

RCP council representation

I am delighted to announce that Dr Robert Gregory, Consultant in Diabetes and Endocrinology at Leicester Royal Infirmary, has been unanimously chosen to represent the three societies on the RCP council.  Dr Gregory takes over from Prof John Wilding of Liverpool and I would like to extend my sincere thanks to Prof Wilding for this important role over the last 3 years, on behalf of the ABCD, DUK and SfE.  Congratulations to Dr Gregory for accepting this role and best wishes for future.